Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Cheryl H. Baker"'
Autor:
Maen Abdelrahim, Md. Riyaz Basha, Ala Abudayyeh, James L. Abbruzzese, Stephen Safe, Cheryl H. Baker, Jimmie Colon, Santhi Konduri
Survivin is overexpressed in most human cancers, including pancreatic adenocarcinoma. Expression of survivin is regulated by specificity protein (Sp) proteins and related to resistance to radiation therapy. Tolfenamic acid induces Sp protein degradat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::734e1f6ae88b84be8c264c76f8b9ffd7
https://doi.org/10.1158/1535-7163.c.6531996
https://doi.org/10.1158/1535-7163.c.6531996
Autor:
Cheryl H. Baker, Srivenugopal S. Kalkunte, Kishor K. Bhakat, Beth Isley, Jimmie Colon, Robert M. Sutphin, George C. Bobustuc, Jonathan Ticku, Santhi D. Konduri
Supplementary Data from Blockade of MGMT Expression by O6 Benzyl Guanine Leads to Inhibition of Pancreatic Cancer Growth and Induction of Apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6694d9878ec631ddc3f820944cb7255f
https://doi.org/10.1158/1078-0432.22440283.v1
https://doi.org/10.1158/1078-0432.22440283.v1
Autor:
Cheryl H. Baker, Srivenugopal S. Kalkunte, Kishor K. Bhakat, Beth Isley, Jimmie Colon, Robert M. Sutphin, George C. Bobustuc, Jonathan Ticku, Santhi D. Konduri
Purpose: We sought to determine whether administration of a MGMT blocker, O6-benzyl guanine (O6BG), at an optimal biological dose alone or in combination with gemcitabine inhibits human pancreatic cancer cell growth.Experimental Design: Human pancrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45146e61a02cb7da3cee4c1a36eda07b
https://doi.org/10.1158/1078-0432.c.6517633.v1
https://doi.org/10.1158/1078-0432.c.6517633.v1
Autor:
Judy Oestreicher, Edward M. Suh, Cheryl H. Baker, Tara P. Pitts, Qunli Xu, Priscilla L. Winder, Patricia Linley, Kaoru Mitsuhashi, Amy E. Wright, Karen TenDyke, Esther A. Guzmán
Publikováno v:
International Journal of Cancer. 139:2116-2126
Pancreatic cancer, the fourth leading cause of cancer death in the United States, has a negative prognosis because metastasis occurs before symptoms manifest. Leiodermatolide, a polyketide macrolide with antimitotic activity isolated from a deep wate
Autor:
Teresa R. Johnson, Aaron Muth, Melissa S. Wason, Cheryl H. Baker, Xianlin Han, Deborah A. Altomare, Navneet Kaur, Veethika Pandey, Otto Phanstiel
Publikováno v:
Journal of Medicinal Chemistry. 57:4023-4034
The motuporamines isolated from the sea sponge Xestospongia exigua are of biological interest because of their unique antimigration and antiangiogenic properties. Key bioactive features were found to be a saturated 15-membered heterocycle and a norsp
Autor:
Sudipta Seal, Soumen Das, Jimmie Colon, Cheryl H. Baker, Melissa S. Wason, James Turkson, Jihe Zhao
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 9:558-569
Side effect of radiation therapy (RT) remains the most challenging issue for pancreatic cancer treatment. In this report we determined whether and how cerium oxide nanoparticles (CONPs) sensitize pancreatic cancer cells to RT. CONP pretreatment enhan
Autor:
Rafael Madero-Visbal, Beatrice Alvarado, Jimmie Colon, Melissa S. Wason, Beth Isley, Cheryl H. Baker, R. Manon, Chris M. Lee, Sudipta Seal, Soumen Das
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 8:1223-1231
This article reports the evaluation of cerium oxide (CeO 2 ) nanoparticles' ability to decrease xerostomia and radiation-induced dermatitis in mice after head and neck radiation. Mice were irradiated using an IC160 x-ray system. Two cohorts were incl
Autor:
Suresh Babu, Jimmie Colon, Melissa Hirsch Kuchma, Artëm E. Masunov, Justin M. Summy, Andrew Teblum, Cheryl H. Baker, Beatrice Alvarado, Sudipta Seal, Christopher Bligh Komanski
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 6:738-744
In an effort to characterize the interaction of cerium oxide nanoparticles (CNPs) in biological systems, we explored the reactivity of CNPs with the phosphate ester bonds of p-nitrophenylphosphate (pNPP), ATP, o-phospho-l-tyrosine, and DNA. The activ
Autor:
Cheryl H. Baker, David Sheikh-Hamad, Beatrice Alvarado, Riyaz Basha, Maen Abdelrahim, Luis J. Herrera, Ala Abudayyeh, Stephen Safe, Rafael Madero-Visbal, Jimmie Colon, Santhi D. Konduri
Publikováno v:
Investigational New Drugs. 29:41-51
The nonsteroidal anti-inflammatory drug (NSAID), tolfenamic acid (TA) is emerging as a new anti-cancer agent. TA induces the degradation of specific Specificity protein (Sp) transcription factors, Sp1, Sp3 and Sp4 which are associated with tumor grow
Autor:
Srivenugopal S. Kalkunte, Cheryl H. Baker, Robert M. Sutphin, Jonathan Ticku, George C. Bobustuc, Jimmie Colon, Santhi D. Konduri, Beth Isley, Kishor K. Bhakat
Publikováno v:
Clinical Cancer Research. 15:6087-6095
Purpose: We sought to determine whether administration of a MGMT blocker, O6-benzyl guanine (O6BG), at an optimal biological dose alone or in combination with gemcitabine inhibits human pancreatic cancer cell growth. Experimental Design: Human pancre